Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

AbbVie to Pay Shire $1.64B Fee Over Canceled Merger

October 21, 2014 | Comments

AbbVie is walking away from its proposed $55 billion takeover bid of Shire and has agreed to pay the rival drugmaker a $1.64 billion breakup fee. The two companies said the deal was off following the decision last week by AbbVie's board to withdraw support from the proposed acquisition.

TOPICS:

CVS Tacks Tobacco Payment to Prescription Network

October 21, 2014 10:49 am | by TOM MURPHY, AP Business Writer | Comments

First, CVS Health pulled tobacco from its store shelves. Now, it plans to make some customers think twice about filling prescriptions at other stores that still sell smokes. The nation's second-largest drugstore chain is developing a new tobacco-free pharmacy network for clients of its Caremark pharmacy benefits management business.

TOPICS:

Interim Shire Chief Financial Officer to Step Down

October 21, 2014 9:06 am | Comments

Shire has announced that James Bowling, Interim Chief Financial Officer, has notified the Board of Directors of his decision to step down from his current role to pursue a new career opportunity as CFO of Severn Trent plc.      

TOPICS:

Boehringer Ingelheim Starts Global Phase III Study for Colorectal Cancer Treatment

October 21, 2014 8:30 am | Comments

Boehringer Ingelheim today announced enrollment of the first patient in a new global Phase III study in patients with metastatic colorectal cancer (mCRC). Colorectal cancer is the third most common cancer in the world, with nearly 1.4 million new cases diagnosed each year.

TOPICS:
Advertisement

CDC Releases Revised Ebola Gear Guidelines

October 21, 2014 8:07 am | by MIKE STOBBE, Associated Press; EMILY SCHMALL, Associated Press | Comments

Federal officials are going on the road with new guidelines to promote head-to-toe protection for health workers treating Ebola patients. Centers for Disease Control and Prevention officials will be demonstrating the recommended techniques Tuesday at a massive training at New York City's Javits Center, with an expected attendance of thousands.

TOPICS:

WHO: Ebola Vaccine Trials Could Start in West Africa in January

October 21, 2014 8:00 am | Comments

A top World Health Organization official says the hunt for an Ebola vaccine will produce data about whether they are safe by December — and they could be in experimental field use by January.          

TOPICS:

FDA Recommends Approval of Novartis’ AIN457 (secukinumab) for Moderate-to-Severe Plaque Psoriasis

October 20, 2014 3:28 pm | Comments

Novartis announced the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) to the FDA voted 7 to 0 to support the approval of AIN457, a selective interleukin-17A inhibitor, for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.

TOPICS:

NewLink Genetics Rises on Roche Cancer Partnership

October 20, 2014 2:59 pm | Comments

NewLink said it will get $150M upfront from Genentech, and could receive more than $1B in payments based on milestones, as well as royalties if the drug is approved. The drug, now called NLG919, is in early-stage clinical testing.    

TOPICS:

EU Seeks $1.27B in Ebola Aid for West Africa

October 20, 2014 2:19 pm | by RAF CASERT, Associated Press | Comments

The European Union committed itself to step up efforts toward getting 1 billion euros ($1.27 billion) in aid to fight Ebola in West Africa and rejected the idea of halting direct flights coming from the region.       

TOPICS:
Advertisement

Canadian Law Professor Urges Country to Cancel Ebola Vaccine License with NewLink, Transfer Rights to Bigger Company

October 20, 2014 1:57 pm | by Helen Branswell, The Canadian Press | Comments

A prominent law professor is urging the federal government to terminate an American company's licence for a Canadian-made Ebola vaccine. The company, NewLink Genetics, doesn't have the capacity to develop the much-needed vaccine, argues Amir Attaran, a professor of law and population health at the University of Ottawa.

TOPICS:

Cubist Pharma CEO Bonney to Retire

October 20, 2014 1:35 pm | Comments

Antibiotic maker Cubist Pharmaceuticals said that Michael Bonney will retire as CEO at the end of the year, and the company said it will promote President Robert Perez to take his place.           

TOPICS:

Valeant Considering Higher Bid for Allergan after Reporting Strong Q3 Results

October 20, 2014 1:26 pm | by Ross Marowits, The Canadian Press | Comments

Valeant Pharmaceuticals said that its strong third-quarter results and a higher growth forecast give it ammunition to win over reluctant takeover target Botox maker Allergan with an increased bid at the appropriate time.     

TOPICS:

BioProcess Technology Consultants Acquires CTD Quality Consulting

October 20, 2014 9:37 am | Comments

CTD Quality Consulting, founded in 2004, specializes in regulatory submissions, regulatory strategy, GxP compliance training, and inspection readiness for pharmaceutical, biopharmaceutical, and medical device companies      

TOPICS:

Halozyme Receives FDA Approval for Additional Manufacturing Facilities For Hylenex Recombinant

October 20, 2014 9:02 am | Comments

The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the Patheon facility in Greenville, North Carolina, for production of finished Hylenex product.

TOPICS:

Ebola Lapses Persisted for Days at Dallas Hospital

October 20, 2014 8:31 am | by MATT SEDENSKY, Associated Press | Comments

Just minutes after Thomas Eric Duncan arrived for a second time at the emergency room, the word is on his chart: "Ebola." But despite all the warnings that the deadly virus could arrive unannounced at an American hospital, for days after the admission, his caregivers are vulnerable.

TOPICS:

China Gives $6M for Food in Ebola Countries

October 20, 2014 8:24 am | Comments

China has donated $6 million to help stave off food shortages in the three African countries worst affected by the Ebola virus, the World Food Program announced Monday, part of Beijing's growing assistance to a continent where its companies have become major investors.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading